0001062993-12-001712.txt : 20120514
0001062993-12-001712.hdr.sgml : 20120514
20120514131107
ACCESSION NUMBER: 0001062993-12-001712
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120510
FILED AS OF DATE: 20120514
DATE AS OF CHANGE: 20120514
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gao David
CENTRAL INDEX KEY: 0001331795
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34566
FILM NUMBER: 12837629
MAIL ADDRESS:
STREET 1: C/ BEIJING MED-PHARM CORPORATION
STREET 2: 600 W. GERMANTOWN PIKE, SUITE 400
CITY: PLYMOUTH MEETING
STATE: PA
ZIP: 19462
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: China Biologic Products, Inc.
CENTRAL INDEX KEY: 0001369868
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 752308816
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: NO.14 EAST HUSHAN ROAD
CITY: TAI'AN CITY, SHANDONG
STATE: F4
ZIP: 271000
BUSINESS PHONE: 86-538-620-3897
MAIL ADDRESS:
STREET 1: NO.14 EAST HUSHAN ROAD
CITY: TAI'AN CITY, SHANDONG
STATE: F4
ZIP: 271000
FORMER COMPANY:
FORMER CONFORMED NAME: GRC Holdings, Inc.
DATE OF NAME CHANGE: 20060721
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0305
4
2012-05-10
0001369868
China Biologic Products, Inc.
CBPO
0001331795
Gao David
18TH FLOOR, JIALONG INTERNATIONAL
BUILDING, 19 CHAOYANG PARK ROAD
BEIJING
F4
100125
CHINA
1
1
0
0
Chief Executive Officer
Common Stock
2012-05-11
4
P
0
4290
9.50
A
4290
I
By Spouse
Stock Option (right to buy)
9.23
2012-05-10
4
A
0
300000
0
A
2022-05-11
Common Stock
300000
320000
D
Granted pursuant to a stock option agreement dated May 11, 2012 between the Company and Mr. Gao (the "Stock Option Agreement"). Pursuant to the Stock Option Agreement, the stock options will vest in twelve equal portions on a quarterly basis over a 3-year period, with the first portion vesting on August 11, 2012, provided that Mr. Gao is employed by the Company on each vesting date.
As of May 14, 2012, Mr. Gao is the holder of stock options to purchase an aggregate of 320,000 shares of common stock of the Issuer, among which the stock options to purchase 20,000 shares were granted pursuant to a stock option agreement dated as of October 6, 2011 between the Company and Mr. Gao.
/s/ David (Xiaoying) Gao
2012-05-14